Nonalcoholic fatty liver disease (Homo sapiens)

From WikiPathways

Description

Quality Tags

Ontology Terms

Bibliography

View all...

1. Dattaroy D, Pourhoseini S, Das S, Alhasson F, Seth RK, Nagarkatti M, Michelotti GA, Diehl AM, Chatterjee S; ''Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis.''; Am J Physiol Gastrointest Liver Physiol, 2015 PubMed Europe PMC Scholia
2. Seki E, Brenner DA, Karin M; ''A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.''; Gastroenterology, 2012 PubMed Europe PMC Scholia
3. Loomba R, Lawitz E, Mantry PS, Jayakumar S, Caldwell SH, Arnold H, Diehl AM, Djedjos CS, Han L, Myers RP, Subramanian GM, McHutchison JG, Goodman ZD, Afdhal NH, Charlton MR; ''Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.''; Cancer Lett, 2018 PubMed Europe PMC Scholia
4. Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L; ''Molecular mechanisms involved in NAFLD progression.''; J Mol Med (Berl), 2009 PubMed Europe PMC Scholia
5. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ; ''Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.''; Gastroenterology, 2003 PubMed Europe PMC Scholia
6. Larter CZ, Farrell GC; ''Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?''; J Hepatol, 2006 PubMed Europe PMC Scholia
7. Armstrong LE, Guo GL; ''Role of FXR in Liver Inflammation during Nonalcoholic Steatohepatitis.''; Curr Pharmacol Rep, 2017 PubMed Europe PMC Scholia
8. Malhi H, Kaufman RJ; ''Endoplasmic reticulum stress in liver disease.''; J Hepatol, 2011 PubMed Europe PMC Scholia
9. Farrell GC, van Rooyen D, Gan L, Chitturi S; ''NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.''; Gut Liver, 2012 PubMed Europe PMC Scholia
10. Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM; ''Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.''; Free Radic Biol Med, 2008 PubMed Europe PMC Scholia
11. Hotamisligil GS; ''Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.''; Cell, 2010 PubMed Europe PMC Scholia

History

View all...

Compare	Revision	Action	Time	User	Comment
	138900	view	00:24, 7 May 2025	Eweitz	Modified description
	138899	view	00:24, 7 May 2025	Eweitz	Ontology Term : 'metabolic dysfunction-associated steatohepatitis' added !
	138898	view	00:23, 7 May 2025	Eweitz	Modified description
	135137	view	21:36, 6 August 2024	Eweitz	Refine membrane layer
	135136	view	21:32, 6 August 2024	Eweitz	Economize layout
	134794	view	02:46, 27 July 2024	Eweitz	Refine legend
	134793	view	02:45, 27 July 2024	Eweitz	Standardize case
	123350	view	10:46, 17 July 2022	Egonw	Made multiple pathways clickable
	98945	view	17:56, 16 October 2018	AlexanderPico	Ontology Term : 'liver disease pathway' added !
	98944	view	17:55, 16 October 2018	AlexanderPico	Ontology Term : 'disease pathway' added !
	98943	view	17:55, 16 October 2018	AlexanderPico	Ontology Term : 'nonalcoholic fatty liver disease' added !
	98942	view	17:55, 16 October 2018	AlexanderPico	Ontology Term : 'hepatocyte' added !
	98933	view	10:52, 16 October 2018	Egonw	Replaced a secondary ChEBI identifier.
	98932	view	10:50, 16 October 2018	Egonw	Removed funny chars in identifier.
	98931	view	06:46, 16 October 2018	AlexanderPico	Modified description
	98930	view	06:35, 16 October 2018	AlexanderPico	fixed paste characters in IDs
	98929	view	06:31, 16 October 2018	AlexanderPico	new pathway
	98917	view	18:21, 15 October 2018	AlexanderPico	New pathway

External references

DataNodes

No datanodes

Annotated Interactions

No annotated interactions